HighTower Advisors’s Braskem BAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$23.5K Buy
16,207
+2,308
+17% +$4.8K ﹤0.01% 3788
2026
Q2
$33.9K Sell
13,899
-2,969
-18% -$11.2K ﹤0.01% 3749
2026
Q1
$61.7K Buy
+16,868
New +$63.9K ﹤0.01% 3688
2025
Q1
– Sell
-19,213
Closed -$74.2K – 3762
2024
Q4
$74.2K Buy
19,213
+3,126
+19% +$17.3K ﹤0.01% 3418
2024
Q3
$119K Buy
16,087
+1,200
+8% +$7.87K ﹤0.01% 3277
2024
Q2
$96K Buy
+14,887
New +$118K ﹤0.01% 3213

Other funds holding BAK

HighTower Advisors's BAK Position: Q3 2026 in Review

HighTower Advisors increased its Braskem (BAK) stake by 17% in Q3 2026, buying an estimated $4.8K and bringing the position to 16,207 shares worth $23.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3788.

HighTower Advisors first reported a position in BAK in Q2 2024 and has held it in 6 quarters since. The position peaked at $119K in Q3 2024. 16 funds tracked by Wall St. Rank hold BAK as of Q3 2026.

  • HighTower Advisors held 16,207 shares of Braskem worth $23.5K as of Q3 2026.
  • HighTower Advisors bought 2,308 Braskem shares in Q3 2026, an estimated $4.8K.
  • Braskem made up ﹤0.01% of HighTower Advisors's portfolio in Q3 2026, its #3788 holding.
  • HighTower Advisors first reported a position in Braskem in Q2 2024 and has held it in 6 quarters since.
  • HighTower Advisors's Braskem position peaked at $119K in Q3 2024.
  • 16 funds tracked by Wall St. Rank held Braskem as of Q3 2026.

Based on HighTower Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.